Infectious Disease

Description	Cat. No	Sample	Specification
HBsAg Strip	802072	Serum/Plasma	Dip-stick
HBsAg Device	802086	Serum/Plasma	Cassette
HBsAg Strip	802172	Whole Blood	Dip-stick
HBsAg Device	802186	Whole Blood	Cassette
HBsAb Strip	802272	Serum/Plasma	Dip-stick
HBsAb Device	802286	Serum/Plasma	Cassette
HCV Strip	802372	Serum/Plasma	Dip-stick
HCV Device	802386	Serum/Plasma	Cassette
HIV Strip	802472	Serum/Plasma	Dip-stick
HIV Device	802486	Serum/Plasma	Cassette
Syphilis(TP) Strip	802572	Serum/Plasma	Dip-stick
Syphilis(TP) Device	802586	Serum/Plasma	Cassette
H.Pylori Strip	802672	Serum/Plasma	Dip-stick
H.Pylori Device	802686	Serum/Plasma	Cassette
Chlamydia Strip	802772	Serum/Plasma	Dip-stick
Chlamydia Device	802786	Serum/Plasma	Cassette
HIV Strip	802872	Whole Blood	Dip-stick
HIV Device	802886	Whole Blood	Cassette

Shanghai Biochip Co., Ltd.（SBC） was founded in Aug. 2001. The existing shareholders of the company include some well-known universities, research institutes, hospitals and enterprises in China. In Feb. 2003, the National Development and Reform Commission authorized SBC to build up and operate the National Engineering Center for biochip at Shanghai project. The company is located in the Zhangjiang High-tech Park Biotech&Pharmaceutical Industrial Base in Pudong Shanghai with a total area of 40,000 square meters, a construction area of over 20,000 square meters, and a current employee number of more than 300 people.

In accordance with company's development strategy and the construction requirements raised by National Development and Reform Commission for the National Engineering Center, SBC is committed to applying and promoting biotechnology development and products for life science research、health-care、 drug discovery and other fields. Through more than 10 years of construction and development, the technology innovation service system is established which is based on the core platforms of the biological sample bank, tissue chips, gene expression chips and the next-generation sequencing; The industrialized system which takes molecular medical diagnosis technology and product development as the core competitiveness has been set up; And three main business areas which include the services for research and drugs R&D, molecular medicine inspection services, and production and sales of molecular diagnostic product.

SBC obeys the value idea of “Scientific innovation, Business orientation, Career development”, follows the construction requirements for the National Engineering Center, and strives to make the company an internationally-advanced national bio-chip industrialization base which integrates the function of technology innovation, achievements transformation, comprehensive service and personal training as a whole. What’s more, the company’s strategic goal is to be an innovative benchmark enterprise among the industry with an level internationally-advanced and has the capability of independent research and development. It would make a contribution to the goal of making Shanghai an influential technology innovation center and also contribute to the domestic field of biomedical science and technology innovation and industrialization in our country.